Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily versus every-other-day G-CSF in breast cancer patients
IRCT2016101830363N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of granulocyte colony-stimulating factor in breast cancer (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Pain and Blood cell counts. Started May 2017; status: completed.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT2016101830363N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016101830363N1.